Tata Elxsi in partnership with DENSO Robotics Europe and AAtek, announced the inauguration of the `Robotics and Automation Innovation Lab` at its Frankfurt office. This state-of-the-art facility aims to drive the future of robotics automation across sectors such as medical devices, pharmaceuticals, life sciences and food science. Equipped for both proof-of-concept (POC) and full-scale development, the lab will serve as a research and development hub, focusing on modular automation, accelerating product development, and simplifying maintenance to meet global demand for automation solutions. This includes live demonstrations of high-precision and modular robotic implementations in cell/tissue culture, diagnostics, and sterilised environments. The new facility will specialise in key areas, leveraging AI-driven analytics to support personalised medicine, automated handling of cell cultures in sterile environments, liquid handling and dispensing solutions, hospital lab automation, drug discovery, bioprocessing, and diagnostics. The centre will provide services including product design and engineering, application development, platform engineering, and regulatory compliance support.This unique combination of state-of-the-art technology and deep automation expertise provides customers with a platform to co-create, test, and deploy robotic solutions designed to meet the specific regulatory and operational challenges of the healthcare industry.Designed to foster innovation in the region, the lab is also open to researchers and students from the Frankfurt Innovation Center (FIZ) and the startup ecosystem in the Hessen region. Powered by Capital Market - Live News

Suzuki Motor Corporation and Tata Elxsi inaugurated the `SUZUKI-TATA ELXSI Offshore Development Center` in Pune, India. This dedicated center will drive Suzuki`s innovations in advanced engineering, shaping the future of mobility.Tata Elxsi will support Suzuki in its green mobility vision by aligning with Suzuki`s goals for sustainable innovation in lightweight design, safety, styling and engineering, eco-friendly materials, and advanced simulations to improve time-to-market. The partnership will also focus on next-generation powertrains and software-defined vehicles, fostering energy-efficient solutions for electric, hybrid, and alternative fuel vehicles.Powered by Capital Market - Live News

Tata Elxsi has allotted 2,361 equity shares under ESOP on 10 October 2024. With this allotment, the paid up equity share capital has increased to Rs. 62,28,19,760 divided into 6,22,81,976 equity shares of Rs. 10 each. Powered by Capital Market - Live News

Net profit of Tata Elxsi rose 14.70% to Rs 229.43 crore in the quarter ended September 2024 as against Rs 200.02 crore during the previous quarter ended September 2023. Sales rose 8.32% to Rs 955.09 crore in the quarter ended September 2024 as against Rs 881.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales955.09881.70 8 OPM %27.8929.89 - PBDT325.85288.87 13 PBT298.70263.86 13 NP229.43200.02 15 Powered by Capital Market - Live News

Tata Elxsi will hold a meeting of the Board of Directors of the Company on 10 October 2024.Powered by Capital Market - Live News